Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-25-042643
Filing Date
2025-04-30
Accepted
2025-04-30 17:03:22
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A hook-20241231x10ka.htm   iXBRL 10-K/A 612814
2 EXHIBIT 31.3 hook-20241231xex31d3.htm EX-31.3 6190
3 EXHIBIT 31.4 hook-20241231xex31d4.htm EX-31.4 6219
  Complete submission text file 0001104659-25-042643.txt   1252444

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hook-20241231.xsd EX-101.SCH 5100
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hook-20241231_def.xml EX-101.DEF 20017
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20241231_lab.xml EX-101.LAB 30488
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20241231_pre.xml EX-101.PRE 20958
21 EXTRACTED XBRL INSTANCE DOCUMENT hook-20241231x10ka_htm.xml XML 137619
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38869 | Film No.: 25896700
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)